Abridge Stock

www.abridge.comHealthcare / Healthcare softwareFounded: 2018Funding to Date: $207.98MM

Abridge, founded in 2018, is a healthcare technology startup bringing generative AI to the medical field. The platform integrates with electronic health records (EHRs) to help healthcare providers minimize time spent on administrative tasks, enabling a focus on patient care. By summarizing medical notes and conversations, Abridge targets healthcare providers seeking to streamline documentation. The company is headquartered in Pittsburgh, Pennsylvania.

Register To Buy and Sell Shares

For more details on financing and valuation for Abridge, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Abridge’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Abridge.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Abridge investors also invested in these private companies


Management Team

Shivdev Rao MD
Co-Founder & Chief Executive Officer
Julia Chapin
Chief Operating Officer
Sandeep Konam
Co-Founder & Chief Technology Officer
Zachary Lipton Ph.D
Chief Technology Officer, Chief Science Officer & Scientific Advisor
Tina Shah
Chief Clinical Officer
Brian Wilson
Chief Commercial Officer
Lindsey Spellman
Head of Marketing

Board Members

Andrew Weissman JD
Union Square Ventures

Abridge’s stock FAQs


Can you buy Abridge’s stock?

Abridge is not publicly traded on NYSE or NASDAQ in the U.S. To buy Abridge’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Abridge’s stock?

Yes, you can sell stock of a private company like Abridge. Forge can help you sell your Abridge stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Abridge’s stock price?

Abridge is a privately held company and therefore does not have a public stock price. However, you may access Abridge’s private market stock price with Forge Data.

What is Abridge’s stock ticker symbol?

Abridge does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Healthcare startup Abridge raises $150 mln for AI model for clinicians

In a Series C funding round Abridge raised $150 million to streamline AI models for healthcare workers.

Abridge clinches $150M to build out generative AI for medical documentation

Investors continue to pour money into generative AI startups, and Abridge is riding this wave as it rapidly scales its technology across U.S. health systems. The Pittsburgh-based startup banked a hefty $150 million series C funding round to invest in more research and development to build bedrock foundation models to power both improvements to the company's existing technology and new products, CEO Shivdev Rao, M.D., told Fierce Healthcare.

Abridge raises $30M to Accelerate Adoption of its Proven Generative AI Solution across U.S. Healthcare Systems

Abridge, the leader in generative AI for clinical documentation, announced a Series B raise of $30 million, led by Spark Capital. The round also included existing investor Bessemer Venture Partners, as well as several leading healthcare innovators including CVS Health Ventures, Kaiser Permanente Ventures, Lifepoint Health, Mayo Clinic, SCAN Group, UC Investments (University of California), and the American College of Cardiology.
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.